BioVie hit with shareholder class action over NE3107 trial disclosures

BIOVIE INC.

Lawsuit filed Jan 19, 2024 in Nevada federal court (Olmstead v. BioVie Inc., No. 3:24-cv-00035).
Alleges material misrepresentations/omissions about NE3107 study and trial under Sections 10(b) and 20(a).
Class period: Aug 5, 2021 through Nov 29, 2023; seeks unspecified monetary damages and fees.
Company believes lawsuit is without merit and intends to defend vigorously.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.